...
首页> 外文期刊>Skin pharmacology and physiology >Prevention of Cutaneous Penetration and CD1c+Uptake of Pollen Allergens by a Barrier-Enhancing Formulation
【24h】

Prevention of Cutaneous Penetration and CD1c+Uptake of Pollen Allergens by a Barrier-Enhancing Formulation

机译:通过增强屏障的配方防止皮肤渗透和CD1c +吸收花粉过敏原

获取原文
获取原文并翻译 | 示例
           

摘要

Recent studies have shown that pollen proteins can penetrate the impaired skin barrier of atopic patients and exacerbate their disease. In the presented study the effect of a topically applied barrier-enhancing formulation was investigated for its preventive effect on the uptake of pollen allergens into CD1c+ epidermal cells. The pollen proteins were fluorescence labelled and applied on barrier-disrupted excised human skin. CD1c+ cells were selected after magnetic cell sorting and analysed using laser scanning microscopy. In untreated disrupted skin, 81% of the CD1c+ cells contained the fluorescence-labelled pollen allergens. In formulation-pretreated skin only 12% of the CD1c+ cells showed an uptake of pollen allergens. These results encourage the treatment of atopic patients with barrier-enhancing formulations to reduce the impact of pollen on air-exposed skin areas and hence the exacerbation of cutaneous symptoms. (C) 2016 S. Karger AG, Basel
机译:最近的研究表明,花粉蛋白可以穿透特应性患者受损的皮肤屏障并加剧其疾病。在目前的研究中,研究了局部应用的增强屏障的制剂对花粉过敏原吸收到CD1c +表皮细胞中的预防作用。花粉蛋白经过荧光标记,并应用于屏障破坏的切除人皮肤上。在磁性细胞分选后选择CD1c +细胞,并使用激光扫描显微镜进行分析。在未经处理的皮肤中,有81%的CD1c +细胞含有荧光标记的花粉过敏原。在经过制剂预处理的皮肤中,只有12%的CD1c +细胞显示出对花粉过敏原的吸收。这些结果鼓励用增强屏障的制剂治疗特应性患者,以减少花粉对暴露于空气的皮肤区域的影响,从而加剧皮肤症状。 (C)2016 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号